Free Trial
OTCMKTS:BAYRY

Bayer Aktiengesellschaft (BAYRY) Stock Price, News & Analysis

Bayer Aktiengesellschaft logo
$7.95 -0.13 (-1.61%)
As of 07/18/2025 03:59 PM Eastern

About Bayer Aktiengesellschaft Stock (OTCMKTS:BAYRY)

Key Stats

Today's Range
$7.95
$8.12
50-Day Range
$6.24
$8.12
52-Week Range
$4.79
$8.58
Volume
1.27 million shs
Average Volume
395,422 shs
Market Capitalization
$31.24 billion
P/E Ratio
N/A
Dividend Yield
0.25%
Price Target
N/A
Consensus Rating
Buy

Company Overview

Receive BAYRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bayer Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.

BAYRY Stock News Headlines

$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.
See More Headlines

BAYRY Stock Analysis - Frequently Asked Questions

Bayer Aktiengesellschaft's stock was trading at $4.88 at the beginning of 2025. Since then, BAYRY shares have increased by 62.9% and is now trading at $7.95.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) posted its quarterly earnings data on Tuesday, May, 13th. The company reported $0.65 EPS for the quarter, beating the consensus estimate of $0.63 by $0.02. The company earned $15.27 billion during the quarter, compared to analysts' expectations of $13.39 billion. Bayer Aktiengesellschaft had a positive trailing twelve-month return on equity of 13.94% and a negative net margin of 7.26%.

Bayer Aktiengesellschaft subsidiaries include these companies: Asklepios BioPharmaceutical, Care/of, KaNDy Therapeutics, BlueRock Therapeutics, Monsanto Company, Zoner.ag, Dihon Pharmaceutical, and more.

Shares of BAYRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Ex-Dividend for 5/12 Dividend
4/29/2025
Record date for 5/12 Dividend
4/30/2025
Dividend Payable
5/12/2025
Last Earnings
5/13/2025
Today
7/19/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Large Cap Pharma
Sub-Industry
N/A
Current Symbol
OTCMKTS:BAYRY
CIK
1144145
Employees
92,815
Year Founded
1863

Profitability

EPS (Trailing Twelve Months)
($0.92)
Trailing P/E Ratio
N/A
Forward P/E Ratio
6.07
P/E Growth
N/A
Net Income
-$2.76 billion
Net Margins
-7.26%
Pretax Margin
-6.83%
Return on Equity
13.94%
Return on Assets
4.09%

Debt

Debt-to-Equity Ratio
1.07
Current Ratio
1.25
Quick Ratio
0.79

Sales & Book Value

Annual Sales
$50.44 billion
Price / Sales
0.62
Cash Flow
$3.73 per share
Price / Cash Flow
2.13
Book Value
$8.82 per share
Price / Book
0.90

Miscellaneous

Outstanding Shares
3,929,700,000
Free Float
N/A
Market Cap
$31.24 billion
Optionable
Not Optionable
Beta
0.86

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (OTCMKTS:BAYRY) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners